WHO recommended “routine vaccination of young adolescent girls to protect again human papillovirus (or HPV), which causes cervical cancer, in all countries where the prevention of cervical cancer and/or other HPV-related diseases is a public health priority, vaccine introduction is programmatically feasible, sustainable financing can be secured, and the cost-effectiveness of vaccination strategies in the country or region has been duly considered.” The recommendation is presented in a position paper published in the Weekly Epidemiological Record at http://www.who.int/wer/2009/wer8415.pdf
WHO noted that use of the two HPV vaccines marketed internationally should be introduced as part of a coordinated strategy to prevent cervical cancer and other HPV-related diseases. This strategy should include education about reducing behaviours that increase the risk of disease, cervical screening, and diagnosis and treatment of precancerous lesions and cancer.
http://www.who.int/immunization/newsroom/recommendation_HPV_vaccination/en/index.html
The Weekly Epidemiological Record (WER) for 10 April 2009, vol. 84, 15 includes: Outbreak news – Meningococcal disease, African meningitis belt; Human papillomavirus vaccines WHO position paper; WHO Strategic Advisory Group of Experts on immunization: request for nominations.
vaccines and global health :: ethics and policy 